New Research To Address Poorer Outcomes of Young Women with Early Breast Cancer
A new clinical trial called OLIO will investigate if a new treatment option will improve outcomes for young women diagnosed with the most common breast cancer.
A new clinical trial called OLIO will investigate if a new treatment option will improve outcomes for young women diagnosed with the most common breast cancer.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to attendees at the Pitt Street Research Life Sciences Conference, Sydney on 19 September 2024.
Invion Limited (ASX:IVX) wishes to announce that RMW Cho Group Limited (RMWC), the licensor of the Photosoft(TM) technology, has successfully completed a Phase II prostate cancer trial (ACTRN12621000633886) using a sublingual (under the tongue) formulation of INV043.
The Sage Group Inc. today announced that Chris Rossidis will join the firm as an Executive Director (https://www.linkedin.com/in/chris-rossidis-a5b42a1a/).
KUR International, a global healthcare conglomerate dedicated to furthering science, research, and patient well-being, today announced John Giammona, PhD, has been appointed President and Chief Commercial Officer.
Penta Security, a leading cyber security company and provider of web application security in the Asia-Pacific region, announced that Penta Security’s latest Cloudbric Managed Rules, API Protection, showed outstanding performance in the comparative test audited by The Tolly Group.
Melbourne Skin & Dermatology has introduced a new program focused on state-of-the-art skin cancer detection and treatment. This initiative aims to enhance the clinic’s ability to identify and address skin cancer with the latest technology and methods.